Skip to main content
Log in

Reply to: do marathon runners face an “ominous” risk of myocardial fibrosis?

  • Reply
  • Published:
European Journal of Applied Physiology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  • Benito B, Gay-Jordi G, Serrano-Mollar A, Guasch E, Shi Y, Tardif JC, Brugada J, Nattel S, Mont L (2011) Cardiac arrhythmogenic remodelling in a rat model of long-term intensive exercise training. Circulation 123(1):13–22

    Article  PubMed  Google Scholar 

  • Breuckmann F, Mohlenkamp S, Nassenstein K, Lehmann N, Ladd S, Schmermund A, Sievers B, Schlosser T, Jockel KH, Heusch G, Erbel R, Barkhausen J (2009) Myocardial late gadolinium enhancement: prevalence, pattern, and prognostic relevance in marathon runners. Radiology 251(1):50–57

    Article  PubMed  Google Scholar 

  • Kawara T, Derksen R, de Groot JR, Coronel R, Tasseron S, Linnenbank AC, Hauer RN, Kirkels H, Janse MJ, de Bakker JM (2001) Activation delay after premature stimulation in chronically diseased human myocardium relates to the architecture of interstitial fibrosis. Circulation 104(25):3069–3075

    Article  PubMed  CAS  Google Scholar 

  • La Gerche A, Robberecht C, Kuiperi C, Nuyens D, Willems R, de Ravel T, Matthijs G, Heidbuchel H (2010) Lower than expected desmosomal gene mutation prevalence in endurance athletes with complex ventricular arrhythmias of right ventricular origin. Heart 96(16):1268–1274

    Article  PubMed  CAS  Google Scholar 

  • Rowe WJ (1993) Endurance exercise and injury to the heart. Sports Med 16(2):73–79

    Article  PubMed  CAS  Google Scholar 

  • Shephard RJ (2010) Do marathon runners face an “ominous” risk of myocardial fibrosis? Eur J Appl Physiol

  • Whyte GP, Sheppard M, George KP, Shave RE, Wilson M, Stephens N, Senior R, Sharma S (2007) Arrhythmias and the athlete: mechanisms and clinical significance. Eur Heart J 28(11):1399–1401 author reply 1401

    Article  PubMed  Google Scholar 

  • Whyte G, Sheppard M, George K, Shave R, Wilson M, Prasad S, O’Hanlon R, Sharma S (2008) Post-mortem evidence of idiopathic left ventricular hypertrophy and idiopathic interstitial myocardial fibrosis: is exercise the cause? Br J Sports Med 42(4):304–305

    Article  PubMed  CAS  Google Scholar 

  • Wilson M, O’Hanlon R, Basavarajaiah S, George K, Green D, Ainslie P, Sharma S, Prasad S, Murrell C, Thijssen D, Nevill A, Whyte G (2010) Cardiovascular function and the veteran athlete. Eur J Appl Physiol 110(3):459–478

    Article  PubMed  CAS  Google Scholar 

  • Wilson MG, O’Hanlon R, Prasad S, Deighan A, Macmillan P, Oxborough D, Godfrey R, Smith G, Sharma S, Maceira A, George K Whyte G (2011) Diverse patterns of myocardial fibrosis in lifelong, veteran endurance athletes. J Appl Physiol (in press)

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M. G. Wilson.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wilson, M.G., O’Hanlon, R., Prasad, S.K. et al. Reply to: do marathon runners face an “ominous” risk of myocardial fibrosis?. Eur J Appl Physiol 111, 1227–1229 (2011). https://doi.org/10.1007/s00421-011-1895-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00421-011-1895-2

Keywords

Navigation